Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Relative market share
Share of market segment relative to largest competitor.
Relative market share compares the market share of a company with that of its next biggest rival.
A company which has a relative Market share means that they are the market leader which eclipses their competitor by this factor. A relative market share also demonstrates how far away a company is from being the market leader.
See also:
Market leader
Market research
Related terms
Black space , Mission statement, One-on-one interview, Diversification, Cartel, Publication planning, Market growth rate, Narrowcasting, McKinsey Seven S's of Management (or 7-S Model), Market follower, Direct response advertising (DRA), Market segmentation, Market niche, Qualitative research, Quantitative research,
Subscribe to our email news alerts
Featured jobs
- Senior Account Manager, Patient/ Medical Communications agency, ...
-
Highly competitive salary
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Lilly’s donanemab shows promise in early symptomatic Alzheimer's comparator study
- GSK’s Jemperli shows promise in phase 3 endometrial cancer trial
- MHRA approves LEO Pharma’s Adtralza for adolescent patients with atopic dermatitis
- World-first trial launches in UK to assess stem cell transplants as first-line MS treatment
- bluebird bio sells Rare Pediatric Disease Priority Review Voucher
- Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations
- Infographic: Therapy Watch Hyperlipidaemia
- Article: The rise of the healthcare influencer
- EMA’s emergency task force backs bivalent COVID-19 vaccines for primary vaccination
- Pfizer and Clear Creek Bio partner on COVID-19 antiviral research programme
- Gilead announces positive new data for Trodelvy in metastatic breast cancer
- Lilly shares positive Verzenio data as adjuvant early breast cancer therapy
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Concerns about data security are building a strong case for clinical mobility in EMEA
- AstraZeneca to acquire Neogene Therapeutics in $320m deal
- Conference discusses global targets in fight against antimicrobial resistance
- GSK’s vaccines president Debruyne heads for the exit
- Lilly’s donanemab shows promise in early symptomatic Alzheimer's comparator study
